Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946853 · ClinicalTrials.gov registry record · NA
Junctional AV Ablation in CRT-D: JAVA-CRT
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02946853 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 26 participants.
The verdict
NCT02946853, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Cardiac resynchronization therapy (CRT) is a demonstrably effective device intervention for patients with heart failure with reduced ejection fraction and specific indication. However, many patients with heart failure (HF) are unable to maintain sinus rhythm and approximately 30-36% of CRT patients are in atrial fibrillation (AF).
Interventions
- PROCEDURE Atrioventricular junctional (AVJ) ablation
- DEVICE Cardiac resynchronization therapy - defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02946853
The ClinicalTrials.gov registry entry for NCT02946853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Atrioventricular junctional (AVJ) ablation is the first listed.
NCT02946853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02946853 about?
NCT02946853 is a clinical study titled "Junctional AV Ablation in CRT-D: JAVA-CRT". Cardiac resynchronization therapy (CRT) is a demonstrably effective device intervention for patients with heart failure with reduced ejection fraction and specific indication. However, many patients with heart failure (HF) are unable to maintain sinus rhythm and approximately 30-36% of CRT patients ...
What is the current status of trial NCT02946853?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-10-01. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT02946853?
The interventions under investigation include: Atrioventricular junctional (AVJ) ablation (PROCEDURE), Cardiac resynchronization therapy - defibrillator (DEVICE).
Who is sponsoring clinical trial NCT02946853?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.